NIAID researchers present new findings at retrovirus meeting. National Institute of Allergy and Infectious Diseases. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.

Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

NIAID AIDS Agenda. 1997 Mar;:4, 11. Unique Identifier : AIDSLINE AIDS/97702457
Doepel L; Folkers G

Abstract: Research presented at the Third Conference on Retroviruses and Opportunistic Infections included reports on partial restoration of immune function and prolonged survival in people with HIV. Findings from several studies are highlighted. ACTG 315 suggests that potent new drug cocktails may partially restore immune system function. ACTG 193A demonstrates that three antiretrovirals are more effective than two for delaying disease progression and prolonging survival in individuals with advanced HIV disease. Other studies presented new findings on the HIV disease process and the complex interactions between the virus and the human immune system.

Keywords: Anti-HIV Agents/*THERAPEUTIC USE CD4 Lymphocyte Count CD4-Positive T-Lymphocytes/*DRUG EFFECTS Chemokines/*IMMUNOLOGY Clinical Trials Clone Cells Dendritic Cells/IMMUNOLOGY/*VIROLOGY Didanosine/THERAPEUTIC USE Disease Progression Drug Therapy, Combination Female HIV/*DRUG EFFECTS HIV Infections/*DRUG THERAPY/*IMMUNOLOGY HIV Protease Inhibitors/*THERAPEUTIC USE Human Interleukin-10/THERAPEUTIC USE Killer Cells/IMMUNOLOGY Lamivudine/THERAPEUTIC USE Male Pyridines/THERAPEUTIC USE Receptors, Cytokine/IMMUNOLOGY Reverse Transcriptase Inhibitors/*THERAPEUTIC USE Ritonavir/THERAPEUTIC USE Virus Replication/*DRUG EFFECTS Zalcitabine/THERAPEUTIC USE Zidovudine/THERAPEUTIC USE NEWSLETTER ARTICLE MEETING REPORT
970830
M9781266

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .